+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hereditary Angioedema Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • PDF Icon

    Report

  • 96 Pages
  • March 2024
  • Region: Global
  • Prof Research
  • ID: 5596478
Description Jump to:

Quick Summary:

In an industry that continues to evolve and expand, understanding the global hereditary angioedema drug market is crucial for stakeholders and decision-makers. With comprehensive analysis spanning across key regions and countries, this report serves as an indispensable resource for grasping current trends, future potentials, and competitive dynamics. Our robust research offers a window into the market's core mechanisms, providing insights into demand patterns, strategic developments, and pricing factors from 2019 through to the end of the forecast period.

Delving into the hereditary angioedema drug market, the report encompasses a detailed examination of the supply and demand scenery, spotlighting leading players who are shaping the industry's future. Beyond regional analysis, our report also dissects the performance and strategy of identified key and emerging competitors, complemented by a thorough SWOT analysis for each. We expose the trends within the applications segment, with a focus on the distribution channels that include retail, hospital, and online pharmacies. With this report, executives will be equipped with the information needed to make informed decisions that will drive their businesses forward.

This report describes the global market size of Hereditary Angioedema Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Hereditary Angioedema Drug as well as some smaller players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Companies Covered:

  • Pharming Group NV
  • Shire plc
  • CSL Limited
  • iBio Inc.
  • BioCryst Pharmaceuticals Inc.
  • Ionis Pharmaceuticals Inc.
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Hereditary Angioedema Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Hereditary Angioedema Drug Market in North America (2019-2029)
8.1 Hereditary Angioedema Drug Market Size
8.2 Hereditary Angioedema Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Hereditary Angioedema Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Hereditary Angioedema Drug Market in South America (2019-2029)
9.1 Hereditary Angioedema Drug Market Size
9.2 Hereditary Angioedema Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Hereditary Angioedema Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Hereditary Angioedema Drug Market in Asia & Pacific (2019-2029)
10.1 Hereditary Angioedema Drug Market Size
10.2 Hereditary Angioedema Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Hereditary Angioedema Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Hereditary Angioedema Drug Market in Europe (2019-2029)
11.1 Hereditary Angioedema Drug Market Size
11.2 Hereditary Angioedema Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Hereditary Angioedema Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Hereditary Angioedema Drug Market in MEA (2019-2029)
12.1 Hereditary Angioedema Drug Market Size
12.2 Hereditary Angioedema Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Hereditary Angioedema Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Hereditary Angioedema Drug Market (2019-2024)
13.1 Hereditary Angioedema Drug Market Size
13.2 Hereditary Angioedema Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Hereditary Angioedema Drug Market Size by Type
Chapter 14 Global Hereditary Angioedema Drug Market Forecast (2024-2029)
14.1 Hereditary Angioedema Drug Market Size Forecast
14.2 Hereditary Angioedema Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Hereditary Angioedema Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pharming Group NV
15.1.1 Company Profile
15.1.2 Main Business and Hereditary Angioedema Drug Information
15.1.3 SWOT Analysis of Pharming Group NV
15.1.4 Pharming Group NV Hereditary Angioedema Drug Revenue, Gross Margin and Market Share (2019-2024)
15.2 Shire plc
15.2.1 Company Profile
15.2.2 Main Business and Hereditary Angioedema Drug Information
15.2.3 SWOT Analysis of Shire plc
15.2.4 Shire plc Hereditary Angioedema Drug Revenue, Gross Margin and Market Share (2019-2024)
15.3 CSL Limited
15.3.1 Company Profile
15.3.2 Main Business and Hereditary Angioedema Drug Information
15.3.3 SWOT Analysis of CSL Limited
15.3.4 CSL Limited Hereditary Angioedema Drug Revenue, Gross Margin and Market Share (2019-2024)
15.4 iBio Inc.
15.4.1 Company Profile
15.4.2 Main Business and Hereditary Angioedema Drug Information
15.4.3 SWOT Analysis of iBio Inc.
15.4.4 iBio Inc. Hereditary Angioedema Drug Revenue, Gross Margin and Market Share (2019-2024)
15.5 BioCryst Pharmaceuticals Inc.
15.5.1 Company Profile
15.5.2 Main Business and Hereditary Angioedema Drug Information
15.5.3 SWOT Analysis of BioCryst Pharmaceuticals Inc.
15.5.4 BioCryst Pharmaceuticals Inc. Hereditary Angioedema Drug Revenue, Gross Margin and Market Share (2019-2024)
15.6 Ionis Pharmaceuticals Inc.
15.6.1 Company Profile
15.6.2 Main Business and Hereditary Angioedema Drug Information
15.6.3 SWOT Analysis of Ionis Pharmaceuticals Inc.
15.6.4 Ionis Pharmaceuticals Inc. Hereditary Angioedema Drug Revenue, Gross Margin and Market Share (2019-2024)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Hereditary Angioedema Drug Report
Table Data Sources of Hereditary Angioedema Drug Report
Table Major Assumptions of Hereditary Angioedema Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Hereditary Angioedema Drug Picture
Table Hereditary Angioedema Drug Classification
Table Hereditary Angioedema Drug Applications
Table Drivers of Hereditary Angioedema Drug Market
Table Restraints of Hereditary Angioedema Drug Market
Table Opportunities of Hereditary Angioedema Drug Market
Table Threats of Hereditary Angioedema Drug Market
Table COVID-19 Impact For Hereditary Angioedema Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Hereditary Angioedema Drug
Table Cost Structure Analysis of Hereditary Angioedema Drug
Table Key End Users
Table Latest News of Hereditary Angioedema Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Hereditary Angioedema Drug Market
Table Policy of Hereditary Angioedema Drug Market
Table 2019-2029 North America Hereditary Angioedema Drug Market Size
Figure 2019-2029 North America Hereditary Angioedema Drug Market Size and CAGR
Table 2019-2029 North America Hereditary Angioedema Drug Market Size by Application
Table 2019-2024 North America Hereditary Angioedema Drug Key Players Revenue
Table 2019-2024 North America Hereditary Angioedema Drug Key Players Market Share
Table 2019-2029 North America Hereditary Angioedema Drug Market Size by Type
Table 2019-2029 United States Hereditary Angioedema Drug Market Size
Table 2019-2029 Canada Hereditary Angioedema Drug Market Size
Table 2019-2029 Mexico Hereditary Angioedema Drug Market Size
Table 2019-2029 South America Hereditary Angioedema Drug Market Size
Figure 2019-2029 South America Hereditary Angioedema Drug Market Size and CAGR
Table 2019-2029 South America Hereditary Angioedema Drug Market Size by Application
Table 2019-2024 South America Hereditary Angioedema Drug Key Players Revenue
Table 2019-2024 South America Hereditary Angioedema Drug Key Players Market Share
Table 2019-2029 South America Hereditary Angioedema Drug Market Size by Type
Table 2019-2029 Brazil Hereditary Angioedema Drug Market Size
Table 2019-2029 Argentina Hereditary Angioedema Drug Market Size
Table 2019-2029 Chile Hereditary Angioedema Drug Market Size
Table 2019-2029 Peru Hereditary Angioedema Drug Market Size
Table 2019-2029 Asia & Pacific Hereditary Angioedema Drug Market Size
Figure 2019-2029 Asia & Pacific Hereditary Angioedema Drug Market Size and CAGR
Table 2019-2029 Asia & Pacific Hereditary Angioedema Drug Market Size by Application
Table 2019-2024 Asia & Pacific Hereditary Angioedema Drug Key Players Revenue
Table 2019-2024 Asia & Pacific Hereditary Angioedema Drug Key Players Market Share
Table 2019-2029 Asia & Pacific Hereditary Angioedema Drug Market Size by Type
Table 2019-2029 China Hereditary Angioedema Drug Market Size
Table 2019-2029 India Hereditary Angioedema Drug Market Size
Table 2019-2029 Japan Hereditary Angioedema Drug Market Size
Table 2019-2029 South Korea Hereditary Angioedema Drug Market Size
Table 2019-2029 Southeast Asia Hereditary Angioedema Drug Market Size
Table 2019-2029 Australia Hereditary Angioedema Drug Market Size
Table 2019-2029 Europe Hereditary Angioedema Drug Market Size
Figure 2019-2029 Europe Hereditary Angioedema Drug Market Size and CAGR
Table 2019-2029 Europe Hereditary Angioedema Drug Market Size by Application
Table 2019-2024 Europe Hereditary Angioedema Drug Key Players Revenue
Table 2019-2024 Europe Hereditary Angioedema Drug Key Players Market Share
Table 2019-2029 Europe Hereditary Angioedema Drug Market Size by Type
Table 2019-2029 Germany Hereditary Angioedema Drug Market Size
Table 2019-2029 France Hereditary Angioedema Drug Market Size
Table 2019-2029 United Kingdom Hereditary Angioedema Drug Market Size
Table 2019-2029 Italy Hereditary Angioedema Drug Market Size
Table 2019-2029 Spain Hereditary Angioedema Drug Market Size
Table 2019-2029 Belgium Hereditary Angioedema Drug Market Size
Table 2019-2029 Netherlands Hereditary Angioedema Drug Market Size
Table 2019-2029 Austria Hereditary Angioedema Drug Market Size
Table 2019-2029 Poland Hereditary Angioedema Drug Market Size
Table 2019-2029 Russia Hereditary Angioedema Drug Market Size
Table 2019-2029 MEA Hereditary Angioedema Drug Market Size
Figure 2019-2029 MEA Hereditary Angioedema Drug Market Size and CAGR
Table 2019-2029 MEA Hereditary Angioedema Drug Market Size by Application
Table 2019-2024 MEA Hereditary Angioedema Drug Key Players Revenue
Table 2019-2024 MEA Hereditary Angioedema Drug Key Players Market Share
Table 2019-2029 MEA Hereditary Angioedema Drug Market Size by Type
Table 2019-2029 Egypt Hereditary Angioedema Drug Market Size
Table 2019-2029 Israel Hereditary Angioedema Drug Market Size
Table 2019-2029 South Africa Hereditary Angioedema Drug Market Size
Table 2019-2029 Gulf Cooperation Council Countries Hereditary Angioedema Drug Market Size
Table 2019-2029 Turkey Hereditary Angioedema Drug Market Size
Table 2019-2024 Global Hereditary Angioedema Drug Market Size by Region
Table 2019-2024 Global Hereditary Angioedema Drug Market Size Share by Region
Table 2019-2024 Global Hereditary Angioedema Drug Market Size by Application
Table 2019-2024 Global Hereditary Angioedema Drug Market Share by Application
Table 2019-2024 Global Hereditary Angioedema Drug Key Vendors Revenue
Figure 2019-2024 Global Hereditary Angioedema Drug Market Size and Growth Rate
Table 2019-2024 Global Hereditary Angioedema Drug Key Vendors Market Share
Table 2019-2024 Global Hereditary Angioedema Drug Market Size by Type
Table 2019-2024 Global Hereditary Angioedema Drug Market Share by Type
Table 2024-2029 Global Hereditary Angioedema Drug Market Size by Region
Table 2024-2029 Global Hereditary Angioedema Drug Market Size Share by Region
Table 2024-2029 Global Hereditary Angioedema Drug Market Size by Application
Table 2024-2029 Global Hereditary Angioedema Drug Market Share by Application
Table 2024-2029 Global Hereditary Angioedema Drug Key Vendors Revenue
Figure 2024-2029 Global Hereditary Angioedema Drug Market Size and Growth Rate
Table 2024-2029 Global Hereditary Angioedema Drug Key Vendors Market Share
Table 2024-2029 Global Hereditary Angioedema Drug Market Size by Type
Table 2024-2029 Hereditary Angioedema Drug Global Market Share by Type

Companies Mentioned

  • Pharming Group NV
  • Shire plc
  • CSL Limited
  • iBio Inc.
  • BioCryst Pharmaceuticals Inc.
  • Ionis Pharmaceuticals Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Hereditary Angioedema Therapeutics Global Market Report 2024 - Product Image

Hereditary Angioedema Therapeutics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Hereditary Angioedema Therapeutic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Hereditary Angioedema Therapeutic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 180 Pages
  • Global
From
Angioedema Treatment Market by Drugs Type, Route of Administration, End-User - Global Forecast 2025-2030 - Product Image

Angioedema Treatment Market by Drugs Type, Route of Administration, End-User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Angioedema Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Angioedema Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 81 Pages
  • Global
From
Hereditary Angioedema Therapeutics Market by Drug Class, Treatment Type, Route Of Administration - Global Forecast 2025-2030 - Product Image

Hereditary Angioedema Therapeutics Market by Drug Class, Treatment Type, Route Of Administration - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.